Joint Clinical Research Centre

The Joint Clinical Research Centre (JCRC) is a medical research institution in Uganda, specializing in HIV/AIDS treatment and management.
Location.
The headquarters of JCRC are located on Lubowa Hill, at Plot 101 Entebbe Road, approximately , by road, southeast of Kampala, the capital and largest city of Uganda. The geographical coordinates of the institution's headquarters are:0°13'51.0"N, 32°34'00.0"E (Latitude:0.230833; Longitude:32.566667).
Overview.
Founded in 1990, JCRC is a collaborative effort by three Ugandan ministries to address the challenges posed by HIV/AIDS and related infections: (a) the Ministry of Health, (b) the Ministry of Education and (c) the Ministry of Defence. The institution works in close collaboration with Makerere University College of Health Sciences (MUCHS).
Research.
JCRC focuses on HIV/AIDS research in all age groups, clinical trials of ARVs, nutritional and social interventions and the concomitant treatment of tuberculosis. The institution also carries out malaria research. The majority of the institution's research projects are in collaboration with national, regional and international organisations, including funding agencies, international health research institutions, international NGOs and universities, as well as corporate philanthropists.
Governance.
The research centre is administered by an eight-person board of directors, chaired by Justine Opio-Epelu. Other board members include Prof. Nelson Sewankambo, the immediate past Principal of Makerere University College of Health Sciences. Prof. Peter Mugyenyi, the internationally recognized HIV/AIDS researcher and pediatrician, who founded the institution, serves as the centre's executive director.
Future plans.
The JCRC has plans to build an international research hospital worth US$120 million in collaboration with "Tokushukai Medical Group" of Japan. Commitment for 70 percent funding has been obtained from the African Development Bank (AfDB).
In March 2018, the institution procured an Apheresis machine, which enables healthcare personnel to extract only those selected blood components from a donor's or patient's blood, and return the non-selected components back into the bloodstream of the donor/patient. This technique is of particular significance and utility, when treating patients with sickle cell disease and HIV/AIDS.